AstraZeneca (AZN) Short Interest Ratio & Short Volume

$76.90
-0.14 (-0.18%)
(As of 05/17/2024 ET)

AstraZeneca Short Interest Data

Current Short Volume
8,530,000 shares
Previous Short Volume
8,580,000 shares
Change Vs. Previous Month
-0.58%
Dollar Volume Sold Short
$647.26 million
Short Interest Ratio / Days to Cover
1.3
Last Record Date
April 30, 2024
Outstanding Shares
3,100,440,000 shares
Percentage of Shares Shorted
0.28%
Today's Trading Volume
2,791,645 shares
Average Trading Volume
6,123,686 shares
Today's Volume Vs. Average
46%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling AstraZeneca ?

Sign up to receive the latest short interest report for AstraZeneca and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AZN Short Interest Over Time

AZN Days to Cover Over Time

AZN Percentage of Float Shorted Over Time

AstraZeneca Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20248,530,000 shares $647.26 million -0.6%N/A1.3 $75.88
4/15/20248,580,000 shares $589.70 million +12.0%N/A1.4 $68.73
3/31/20247,660,000 shares $518.97 million -26.9%N/A1.2 $67.75
3/15/202410,480,000 shares $694.93 million +13.2%N/A1.7 $66.31
2/29/20249,260,000 shares $594.12 million +3.8%N/A1.5 $64.16
2/15/20248,920,000 shares $560.53 million +117.6%N/A1.4 $62.84
1/31/20244,100,000 shares $273.22 million -29.4%N/A0.7 $66.64
1/15/20245,810,000 shares $403.33 million -6.6%N/A1.1 $69.42
12/31/20236,220,000 shares $418.92 million +8.9%N/A1.1 $67.35
12/15/20235,710,000 shares $370.01 million -27.7%N/A1 $64.80
11/30/20237,900,000 shares $510.26 million -2.5%N/A1.4 $64.59
11/15/20238,100,000 shares $511.35 million -10.1%N/A1.6 $63.13
10/31/20239,010,000 shares $569.70 million +53.8%N/A1.8 $63.23
10/15/20235,860,000 shares $394.55 million -3.9%N/A1.2 $67.33
9/30/20236,100,000 shares $413.09 million -27.2%N/A1.3 $67.72
9/15/20238,380,000 shares $572.10 million +14.3%N/A1.6 $68.27
8/31/20237,330,000 shares $497.12 million +49.0%N/A1.4 $67.82
8/15/20234,920,000 shares $341.99 million -18.7%N/A0.9 $69.51
7/31/20236,050,000 shares $433.79 million -5.2%N/A1.2 $71.70
7/15/20236,380,000 shares $429.88 million -15.9%N/A1.3 $67.38
6/30/20237,590,000 shares $543.22 million +27.1%N/A1.7 $71.57
6/15/20235,970,000 shares $445.48 million +22.3%N/A1.4 $74.62
5/31/20234,880,000 shares $356.63 million +4.5%N/A1.2 $73.08
5/15/20234,670,000 shares $350.20 million -19.6%N/A1.2 $74.99
4/30/20235,810,000 shares $425.41 million +44.5%N/A1.3 $73.22
4/15/20234,020,000 shares $296.92 million +6.1%N/A0.8 $73.86
3/31/20233,790,000 shares $263.06 million +21.5%N/A0.8 $69.41
3/15/20233,120,000 shares $201.49 million -10.1%N/A0.6 $64.58
2/28/20233,470,000 shares $226.17 million +28.5%N/A0.7 $65.18
2/15/20232,700,000 shares $188.16 million +8.0%N/A0.6 $69.69
1/31/20232,500,000 shares $163.43 million -50.3%N/A0.5 $65.37
1/15/20235,030,000 shares $357.53 million +18.9%N/A1 $71.08
12/30/20224,230,000 shares $286.79 million -14.2%N/A0.8 $67.80
12/15/20224,930,000 shares $343.82 million +13.3%N/A0.9 $69.74
11/30/20224,350,000 shares $295.67 million -6.7%N/A0.7 $67.97
11/15/20224,660,000 shares $298.01 million -14.3%N/A0.7 $63.95
10/31/20225,440,000 shares $319.93 million -5.6%N/A0.8 $58.81
10/15/20225,760,000 shares $316.63 million +20.8%N/A0.9 $54.97
9/30/20224,770,000 shares $261.59 million -25.7%N/A0.7 $54.84
9/15/20226,420,000 shares $373.26 million -29.4%N/A1 $58.14
Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

AZN Short Interest - Frequently Asked Questions

What is AstraZeneca's current short interest?

Short interest is the volume of AstraZeneca shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 8,530,000 shares of AZN short. Learn More on AstraZeneca's current short interest.

What is a good short interest ratio for AstraZeneca?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AZN shares currently have a short interest ratio of 1.0. Learn More on AstraZeneca's short interest ratio.

Which institutional investors are shorting AstraZeneca?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AstraZeneca: Walleye Trading LLC, Twin Tree Management LP, SAL Trading LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, Raymond James & Associates, IMC Chicago LLC, and Readystate Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is AstraZeneca's short interest increasing or decreasing?

AstraZeneca saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 8,530,000 shares, a decline of 0.6% from the previous total of 8,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does AstraZeneca's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to AstraZeneca: Novartis AG (0.22%), AbbVie Inc. (0.82%), Abbott Laboratories (0.84%), Pfizer Inc. (1.10%), Merck & Co., Inc. (0.74%), Sanofi (0.22%), Johnson & Johnson (0.74%), Vertex Pharmaceuticals Incorporated (1.50%), Regeneron Pharmaceuticals, Inc. (1.42%), GSK plc (0.44%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short AstraZeneca stock?

Short selling AZN is an investing strategy that aims to generate trading profit from AstraZeneca as its price is falling. AZN shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AstraZeneca?

A short squeeze for AstraZeneca occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AZN, which in turn drives the price of the stock up even further.

How often is AstraZeneca's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZN, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AZN) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners